Core Scientific Balance Sheet Health
Financial Health criteria checks 2/6
Core Scientific has a total shareholder equity of $-729.4M and total debt of $492.5M, which brings its debt-to-equity ratio to -67.5%. Its total assets and total liabilities are $921.9M and $1.7B respectively. Core Scientific's EBIT is $33.9M making its interest coverage ratio 0.3. It has cash and short-term investments of $253.0M.
Key information
-67.5%
Debt to equity ratio
US$492.54m
Debt
Interest coverage ratio | 0.3x |
Cash | US$253.02m |
Equity | -US$729.39m |
Total liabilities | US$1.65b |
Total assets | US$921.85m |
Recent financial health updates
Recent updates
Core Scientific, Inc.'s (NASDAQ:CORZ) P/S Is Still On The Mark Following 35% Share Price Bounce
Nov 08Core Scientific: HPC Pivot Begins To Bear Fruit
Oct 16Market Participants Recognise Core Scientific, Inc.'s (NASDAQ:CORZ) Revenues Pushing Shares 27% Higher
Sep 14Core Scientific: Deserves Better As HPC Moves Into High Gear
Aug 13Core Scientific: HPC Deals And A Buyout Offer
Jun 04Core Scientific, Inc.'s (NASDAQ:CORZ) Revenues Are Not Doing Enough For Some Investors
Apr 24Financial Position Analysis
Short Term Liabilities: CORZ has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: CORZ has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: CORZ has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: CORZ's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CORZ has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: CORZ has sufficient cash runway for 1 years if free cash flow continues to grow at historical rates of 22.7% each year.